ADVERTISEMENT
970x220
.navbar-nav.header-menu { width: 100%; justify-content: center; } .tab-menu-outers .nav-item{ width: unset; } .tab-bar-social.mt-5 { margin-top: 0 !important; } .second-header-menu { margin-top: 27px; padding: 12px 0; border-top: 1px solid #C3C1AE; border-bottom: 1px solid #C3C1AE; } .third-header-menu{ padding: 12px 0; } .bottom-header-menu { margin-right: 25px; text-decoration: none; font-family: "Canicule Display v0.3 Trial" , serif; font-weight: 500; font-size: 15px; line-height: 16px; color: black; } .bottom-header-menu:hover { color: #0A58CA !important; } header .time-date-section { display: flex; align-items: end; } header .mb-header-center .align-items-center .col-3 , header .mb-header-center .align-items-center .col-6, header .top-header-container .col-md-6{ z-index: 100; } header .desktop-menu-bar li:hover a{ background: transparent; color: #2E3192 !important; } @media(max-width: 767px) { header.header.mb-header{ display:none; } .second-header-menu .justify-content-center{ justify-content: start !important; } .second-header-menu ul , .third-header-menu ul{ display: grid; grid-template-columns: 1fr 1fr; width: 100%; } }

No discrimination: Manila LGU distributes over 600 Tocilizumab vials to NCR, LuzViMin areas

Published Sep 14, 2021 12:48 pm  |  Updated Sep 14, 2021 12:48 pm

Over 600 Tocilizumab vials have been distributed by the local government of Manila to parts of Luzon, Visayas, and Mindanao to help these areas cope with the surge in COVID-19 cases, particularly the more transmissible Delta variant.

The local government said a total of 622 vials were given to 12 cities in the National Capital Region (NCR), 17 areas in Luzon, three areas in the Visayas, and three areas in Mindanao.

(MANILA PIO)

The local government denied Facebook posts claiming that Manila Mayor Francisco “Isko Moreno” Domagoso discriminated against persons from the Visayas and Mindanao.

One post, which was branded fake by the City Public Information Office, stated that Domagoso will not allow the entry of individuals coming from Visayas and Mindanao in Manila.

Fake news alert issued by Public Information Office of the City of Manila

Domagoso said he would never discriminate against his fellow Filipinos.

“Hinding hindi po natin ‘yan magagawa sa ating kapwa Pilipino, lalo na ngayong panahon na kailanagn ng pagmamalasakit sa isa’t isa (I will never do that to my fellow Filipinos, specially during this time),” he said.

The mayor said the LGU even sent vials of Tocilizumab and Remdesivir to Visayas and Mindanao areas.

“Hangad ko po ang pagkakaisa ng bawat Pilipino, lalo ngayong panahon ng pandemya. Walang magmamalasakit sa ating mga Pilipino kundi tayo ring kapwa Pilipino (It is my wish to see Filipinos united especially during the pandemic. No one will care for us Filipinos other than our fellow Filipinos),” the mayor said.

ADVERTISEMENT
300x250
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ articles_filter_1564_widget.title }}

.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0 72px 0 12px; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // The two offset values // changed to 10 from 1 , 2 const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } function isNearBottom() { return window.innerHeight + window.scrollY >= document.documentElement.scrollHeight - 100; } function onScroll() { if (isLoading) return; // Skip if already loading if (isNearBottom()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; // Set flag to prevent multiple calls const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { loadCount++; // Increment only after successful execution }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; // Reset flag after execution }); } } window.addEventListener("scroll", onScroll); }); // Mutation Observer for Newly Loaded Articles const observer = new MutationObserver(() => { const articles = document.querySelectorAll(".articles-observe"); if (articles.length > 0) { observeArticles(articles); } }); observer.observe(document.body, { childList: true, subtree: true }); // Intersection Observer for Updating URL function observeArticles(articles) { const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); } } }); }, { threshold: 0.1 } ); articles.forEach(article => intersectionObserver.observe(article)); }
.col-md-12.noPadding.col-xs-12:has(.mb-header-bottom) {padding: 0;} .bottom-footer {color: #fff;background-color: #2E3192;padding: 8px 0;} .bottom-footer .bottom-footer-menu {font-family: Inter;font-weight: 400;font-size: 12px;line-height: 16px;padding: 0px 10px !important;color: #fff !important;text-decoration: none; } .bottom-footer .container {display: flex;justify-content: space-between;align-items: center; } .bottom-footer p{font-family: "Inter";font-weight: 400;font-size: 12px;line-height: 16px;margin-bottom: 0;} .subscribe-button{position: absolute;bottom: 15%;right: 11%;} .subscribe-container {position: fixed;display: flex;align-items: center;background-color: white;height: 50px;border-radius: 50px;box-shadow: 1px 3px 8px 3px rgba(0, 0, 0, 0.2);width: 50px;overflow: hidden;transition: width 0.3s ease-in-out;text-decoration: none;white-space: nowrap; } .subscribe-icon {background-color: #2E3192;color: white;border-radius: 50%;width: 50px;height: 50px;display: flex;align-items: center;justify-content: center;font-size: 18px;flex-shrink: 0;transition: border-radius 0.3s ease-in-out; } .subscribe-text {font-size: 18px;font-weight: bold;color: black;margin-left: 0;margin-right: 0;width: 0;visibility: hidden;opacity: 0;transition: opacity 0.3s ease, width 0.3s ease;} .subscribe-container:hover {cursor: pointer;width: 170px;} .subscribe-container:hover .subscribe-icon {border-bottom-right-radius: 0;border-top-right-radius: 0;} .subscribe-container:hover .subscribe-text {visibility: visible;opacity: 1;margin-left: 10px;margin-right: 10px;width: auto;} h6.footer-heading{ font-weight: 700; } #bottom-footer ul li { display: flex; align-items: center; } @media screen and (min-width: 767px) and (max-width: 991px) { .bottom-footer p, .bottom-footer .bottom-footer-menu{ font-size: 9px; } } @media(max-width: 767px) { .bottom-footer .container {display: block;} .bottom-footer .container .justify-content-center{margin-top: 20px !important;} .bottom-footer .container .justify-content-center .list-group{ width: 100%; display: grid; row-gap: 10px; grid-template-columns: 1fr 1fr 1fr; justify-content: unset; } .bottom-footer p{font-size: 10px;} .subscribe-container { width: 50px !important; overflow: hidden;} .subscribe-container:hover { width: 50px !important;} .subscribe-container .subscribe-text {display: none !important;} .subscribe-button{right: 15%;bottom:7%;} } .mb-header-bottom .header-menu:hover { color: #2E3192 !important; } @media(max-width: 400px) { .bottom-footer .container .justify-content-center .list-group{ grid-template-columns: 1fr 1fr; } }

Sign up by email to receive news.